Intercept Pharmaceuticals... (ICPT)
NASDAQ: ICPT
· Real-Time Price · USD
19.00
0.04 (0.21%)
At close: Nov 07, 2023, 10:00 PM
Intercept Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -57.47M | -187.75M | -189.46M | -174.86M | -194.14M | -64.72M | -68.29M | -91.43M | -107.29M | -170.13M | -222.32M |
Depreciation & Amortization | 377K | 360K | 306K | 592K | 912K | 1.64M | 2.48M | 2.98M | 3.39M | 3.29M | 3.22M |
Stock-Based Compensation | 24.01M | 23.14M | 21.03M | 21.89M | 25.06M | 27.89M | 32.19M | 33.89M | 41.95M | 49.16M | 56.8M |
Other Working Capital | 17.15M | 9.63M | 21.43M | -3.45M | -6.37M | 5.69M | -4.49M | -5.36M | -2.22M | -6.04M | -4.34M |
Other Non-Cash Items | -3.36M | 92.36M | 96.66M | 100.34M | 115.64M | 13.96M | 18.98M | 27.34M | 25.38M | 40.72M | 40.16M |
Deferred Income Tax | -1.28M | -2.43M | 2.58M | 3.33M | 4.67M | -10.78M | -12.44M | -11.78M | -11.71M | 5.03M | 4.94M |
Change in Working Capital | -25.31M | -21.98M | 10.62M | 21.92M | 31.07M | 21.01M | 6.78M | -14.42M | -24.9M | -29.63M | -3.81M |
Operating Cash Flow | -63.02M | -96.29M | -58.25M | -26.78M | -18.12M | 3.11M | -7.11M | -41.64M | -61.47M | -106.58M | -125.94M |
Capital Expenditures | 186K | -135K | -561K | -568K | -865K | -531K | -27K | -397K | -2.3M | -3.63M | -3.84M |
Cash Acquisitions | -4.55M | 55.23M | 55.23M | 55.23M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -332.85M | -459.6M | -465.58M | -552.74M | -472.09M | -501.47M | -441.71M | -349.46M | -326.52M | -230.93M | -346.8M |
Sales Maturities Of Investments | 499.93M | 535.58M | 444.53M | 451.92M | 441.83M | 418.28M | 406.91M | 420.58M | 414.06M | 439.15M | 532.98M |
Other Investing Acitivies | -1.6M | 301.85M | 301.72M | 293.73M | 364.29M | -83.2M | -34.81M | 71.12M | 87.54M | 208.22M | 186.18M |
Investing Cash Flow | 161.11M | 432.92M | 335.39M | 261.85M | 332.11M | -83.73M | -34.83M | 70.73M | 85.24M | 204.59M | 182.34M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | -428K | -530K | -508K | -557K | -628K | -76.58M | -76.8M | -77.56M | -77.57M | -1.71M | -1.75M |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -115.97M | -263.37M | -267.25M | -267.32M | -262.61M | -1.82M | 1.88M | 1.12M | 1.93M | -1.69M | -1.02M |
Financial Cash Flow | -115.97M | -263.37M | -267.25M | -267.32M | -262.61M | -1.82M | 1.88M | 1.12M | 1.93M | -1.69M | -1.02M |
Net Cash Flow | -16.52M | 70.36M | 3.55M | -38.55M | 43.21M | -86.67M | -40.91M | 28.75M | 25.47M | 96.74M | 53.96M |
Free Cash Flow | -62.83M | -96.43M | -58.81M | -27.35M | -18.99M | 2.58M | -7.14M | -42.04M | -63.77M | -110.21M | -129.78M |